REGENXBIO Inc.
RGNX | NASDAQ
$7.88
-$0.15 (-1.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.88
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $415.13M
Enterprise Value $370.81M
Beta 0.93
Average Volume 1.92M
Shares Outstanding (Diluted) 53.02M
Shares Change YoY 2.98%
Institutional Ownership 81.24%
Exchange NASDAQ
ISIN US75901B1070
Price Performance
Price Change 1M -5.0%
Price Change 3M -20.8%
Price Change 6M -6.9%
Price Change YTD -41.9%
Price Change 1Y -13.0%
Price Change 3Y -54.0%
Price Change 5Y -81.4%
1M CAGR (ann.) -28.8%
1Y CAGR (ann.) -11.1%
5Y CAGR (ann.) -24.7%
All-Time CAGR -11.4%
Valuation
PE Ratio -2.08
Forward PE N/A
PEG Ratio 0.05
Forward PEG 0.16
PS Ratio 2.33
Forward PS 1.90
PB Ratio 5.68
P/FCF Ratio -1.25
P/Adj. FCF Ratio -1.10
P/OCF Ratio -1.69
EV/Sales 2.13
EV/EBIT -2.40
EV/EBITDA -2.67
EV/FCF -1.13
Earnings Yield -48.1%
FCF Yield -80.3%
Adj. FCF Yield -91.0%
Financial Health
Net Cash $36.57M
Total Debt $68.95M
Cash & Short-Term Investments $105.52M
Total Assets $386.62M
Current Ratio 2.86
Quick Ratio 2.86
Debt / Equity Ratio 0.96
Debt / EBITDA -0.50
Debt / FCF -0.21
OCF / Debt -4.68
Interest Coverage -3.91
Altman Z-Score -3.92
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 54.2%
Operating Profit Margin -94.1%
EBITDA Margin -79.7%
Net Profit Margin -112.6%
FCF Margin -187.5%
Adj. FCF Margin -212.5%
SBC / Revenue 20.1%
SBC Impact (per share) -13.4%
Returns
Return on Assets -50.8%
Return on Equity -220.1%
Return on Invested Capital -52.7%
Return on Capital Employed -54.0%
Return on Tangible Assets -50.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 21.6%
Revenue CAGR 5Y 1.6%
Revenue CAGR 10Y 35.5%
EPS CAGR 3Y 17.8%
EPS CAGR 5Y -24.6%
EPS CAGR 10Y -16.5%
FCF CAGR 3Y -32.4%
FCF CAGR 5Y -49.9%
FCF CAGR 10Y -23.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 20
EPS Growth Next 3Y 36.9%
Revenue Growth Next 3Y 48.6%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$1.21
EPS Growth Est (next Q) 0.7%
Revenue Est (next Q) $15.86M
Revenue Growth Est (next Q) -46.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $19.60
Price Target Upside 148.7%
Cash Flow
Operating Cash Flow $-322.86M
Free Cash Flow $-327.09M
Adj. Free Cash Flow $-370.75M
FCF Per Share -$4.73
OCF Per Share -$4.67
OCF/S Ratio -141.4%
Income Statement
Revenue $174.48M
Gross Profit $94.61M
Operating Income $-164.15M
EBITDA $-139.12M
Net Income $-196.43M
EPS (Diluted) -$3.79
Revenue / Employee $470.3K
Profit / Employee $-529.47K
Employees 371
Add to Watchlist
Select watchlists to add or remove RGNX